Boston-based TA Associates has sold its portfolio company, Microban, a provider of branded antimicrobial ingredients, to W.M. Barr. The terms of the transaction were not disclosed. M&A investment bank The Valence Group advised TA Associates on the transaction.
The Valence Group, a specialist M&A investment bank offering advisory services to companies and investors in the chemicals, materials and related sectors, advised TA Associates, a Boston-based private equity firm, on the sale of its portfolio company, Microban, a world leader in the provision of branded antimicrobial ingredients, to W.M. Barr. The terms of the transaction were not disclosed.
Microban engineers durable antimicrobial solutions for consumer, industrial and medical products around the world. W.M. Barr produces specialty cleaning products serving consumer and industrial customers in the home improvement, household and automotive industries.
“We are delighted to have been involved in the sale of this premier and fast-growing specialty chemical company operating in one of the most attractive sub-sectors of the industry”, said The Valence Group partner, Joshua Hay.
Telly Zachariades, co-founder and partner at The Valence Group, added: “This transaction continues our strong performance of 9 announced transactions in 2011 and firmly establishes Valence as the most active M&A advisor in the chemicals and material industry by some distance”
About The Valence Group
The Valence Group is a specialist M&A investment bank offering advisory services exclusively to companies and investors in the chemicals, materials and related sectors. The Valence Group team includes a unique combination of professionals with backgrounds in investment banking, strategic consulting and senior management within the chemicals and materials industries, all focused exclusively on providing M&A advisory services to the chemicals and materials sector. The senior members of The Valence Group have collectively more than 250 years of experience, more than 200 closed deals valued cumulatively over $80 billion spanning more than 100 different chemicals/materials subsectors. The firm’s offices are located in New York, London, and Shanghai.